Skip to content

Kenvue KVUE Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Kimberly-Clark logo
Kimberly-ClarkKMB
Clorox logo
CloroxCLX
PBH
Prestige Consumer HealthcarePBH
Edgewell Personal Care logo
Edgewell Personal CareEPC
Helen Of Troy logo
Helen Of TroyHELE
Perrigo Company logo
Perrigo CompanyPRGO

Other financials

Income statement

See full
Revenue$3.9B+4.5%
Gross profit$2.3B+6.2%
Operating income$767.0M+37.5%
Net income$474.0M+47.2%
EPS (diluted)$0.25+47.1%

Balance sheet

See full
Cash & equivalents$1.1B+1.7%
Total debt$8.8B-8.3%
Total equity$10.6B+5.5%
Total assets$26.9B+2.3%

Cash flow

See full
Operating cash flow$489.0M+14.3%
CapEx$139.0M-22.3%
Free cash flow$350.0M+40.6%

Valuation

See full
Market cap$36.69B-6.1%
Enterprise value$44.42B-6.4%
P/E22.6×-4.9×
P/S2.4×-0.2×

Profitability

See full
Gross margin58.4%+0.3pp
Operating margin17.2%+5.1pp
Net margin10.6%+3.7pp
FCF margin11.9%+2.4pp

Returns & leverage

See full
Return on equity15.7%+5.5pp
Debt / equity0.8×-0.1×
Current ratio+0.1×

Where this comes from

Reported directly by Kenvue in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Kenvue’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kenvue's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kenvue's preferred stock, shares authorized?
Kenvue (KVUE) reported preferred stock, shares authorized of $750M in Q1 2026.
How has Kenvue's preferred stock, shares authorized changed year-over-year?
Kenvue's preferred stock, shares authorized decreased by 0.0% year-over-year, from $750M to $750M.
What is the long-term trend for Kenvue's preferred stock, shares authorized?
Over 3 years (2022 to 2025), Kenvue's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $750M to $750M.